ReviewFrontiers in cell and developmental biology2022

Pathological implications of metabolic reprogramming and its therapeutic potential in medulloblastoma.

Veronica Marabitti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.